Humanin Levels Explored for Cardiac Surgery Complications

Patients undergoing cardiac operations, such as coronary artery bypass surgery (CABG), face a significant risk of major postoperative complications, often exacerbated by conditions like myocardial ischemia (insufficient blood flow to heart muscle). Humanin, a small mitochondrial-derived peptide, has demonstrated potent cytoprotective and anti-apoptotic properties in various preclinical models. However, its specific concentration in human cardiac tissue and blood plasma, and its direct association with patient outcomes following cardiac surgery, remains an important knowledge gap. This study aimed to clarify the relationship between Humanin-like peptide concentrations and the occurrence of early complications after cardiac operation.

The primary objective of this completed study was to clarify the concentration of Humanin-like peptides in both myocardial tissue and blood plasma, and to investigate whether these concentration levels are directly related to the occurrence and frequency of early complications following cardiac surgery. The study's hypothesis posited a significant relationship between these measured Humanin levels and patient outcomes. While the study successfully completed its data collection with an actual enrollment of 106 participants by August 2019, the provided summary details the study's design and objectives rather than specific results. Therefore, no quantitative findings regarding Humanin concentrations or their statistical association with complications are available in this abstract. The core aim was to determine if specific Humanin levels in cardiac tissue and plasma could serve as indicators or predictors for postoperative complications in patients undergoing coronary artery bypass surgery.